about
Low serum levels of uric acid and albumin in patients with Guillain-Barre syndromeIntravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome.Recent developments and future directions in Guillain-Barré syndrome.Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.Successful treatment of refractory Guillain-Barré syndrome with alemtuzumab in a patient with chronic lymphocytic leukemia.Expression of Early Growth Response Gene-2 and Regulated Cytokines Correlates with Recovery from Guillain-Barré Syndrome.
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Emerging drugs for Guillain-Barré syndrome
@ast
Emerging drugs for Guillain-Barré syndrome
@en
Emerging drugs for Guillain-Barré syndrome
@en-gb
Emerging drugs for Guillain-Barré syndrome
@nl
type
label
Emerging drugs for Guillain-Barré syndrome
@ast
Emerging drugs for Guillain-Barré syndrome
@en
Emerging drugs for Guillain-Barré syndrome
@en-gb
Emerging drugs for Guillain-Barré syndrome
@nl
prefLabel
Emerging drugs for Guillain-Barré syndrome
@ast
Emerging drugs for Guillain-Barré syndrome
@en
Emerging drugs for Guillain-Barré syndrome
@en-gb
Emerging drugs for Guillain-Barré syndrome
@nl
P2860
P1476
Emerging drugs for Guillain-Barré syndrome
@en
P2093
Christa Walgaard
P2860
P304
P356
10.1517/14728214.2011.531699
P407
P577
2011-03-01T00:00:00Z